Disseminated renal adenocarcinoma. Developmental study
Domínguez, C.; Broseta, E.; Boronat, F.; Llopis, B.; Martínez, R.; Jiménez-Cruz, J.F.
Archivos Espanoles de Urologia 42(9): 863-866
1989
ISSN/ISBN: 0004-0614 PMID: 2624487 Document Number: 341185
A study was undertaken on 57 patients diagnosed as having disseminated renal adenocarcinoma. The interval between the onset of symptomatology and diagnosis ranged from 1 to 48 months. The tumor frequently metastasized to lungs and bone. To evaluate survival, this patient population was divided into two groups: those who underwent nephrectomy, 17 patients (9 patients also underwent lymphadenectomy), and those who were put on drug therapy alone. No significant difference was observed with respect to survival for both patient groups.